INTECH Investment Management’s Larimar Therapeutics LRMR Stock Holding History

INTECH Investment Management’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50K	Buy	16,390 +1,861	+13%	+$7.39K	﹤0.01%	2051
2026 Q1	$65.4K	Sell	14,529 -6,439	-31%	-$25.7K	﹤0.01%	1971
2025 Q4	$79.9K	Sell	20,968 -252	-1%	-$980	﹤0.01%	2196
2025 Q3	$68.5K	Sell	21,220 -4,743	-18%	-$17.8K	﹤0.01%	2337
2025 Q2	$75K	Sell	25,963 -7,959	-23%	-$18.4K	﹤0.01%	2357
2025 Q1	$72.9K	Buy	33,922 +19,929	+142%	+$63K	﹤0.01%	2386
2024 Q4	$54.2K	Buy	13,993 +1,040	+8%	+$6.87K	﹤0.01%	2320
2024 Q3	$84.8K	Buy	+12,953	New	+$104K	﹤0.01%	1915

Other funds holding LRMR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

INTECH Investment Management's LRMR Position: Q2 2026 in Review

INTECH Investment Management increased its Larimar Therapeutics (LRMR) stake by 13% in Q2 2026, buying an estimated $7.39K and bringing the position to 16,390 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #2051.

INTECH Investment Management first reported a position in LRMR in Q3 2024 and has held it in 8 quarters since. The position peaked at $84.8K in Q3 2024. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

INTECH Investment Management held 16,390 shares of Larimar Therapeutics worth $50K as of Q2 2026.
INTECH Investment Management bought 1,861 Larimar Therapeutics shares in Q2 2026, an estimated $7.39K.
Larimar Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2051 holding.
INTECH Investment Management first reported a position in Larimar Therapeutics in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Larimar Therapeutics position peaked at $84.8K in Q3 2024.
163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.